With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, according to a study published in Nature. Using population-wide data from ...

Programmable cell‑like particles seek out drug‑resistant bacteria, inject lethal payloads, and spare beneficial microbes.

In a recent observational study published in the journal Immunity, researchers from the United States of America investigated the longevity of antibody responses to severe acute respiratory syndrome ...

By analyzing mice that had been first infected with SARS-CoV-2 and then with influenza A virus, the scientists found that having recovered from COVID had a protective effect against the worst effects ...

A shot of the latest Covid-19 vaccine can help cut the chances of getting a symptomatic infection by half, early data from the US Centers for Disease Control and Prevention suggests. Vaccine ...